Ironwood Pharmaceuticals IRWD Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's interest income?
- Ironwood Pharmaceuticals (IRWD) reported interest income of $1.7M in Q1 2026.
- How has Ironwood Pharmaceuticals's interest income changed year-over-year?
- Ironwood Pharmaceuticals's interest income increased by 95.4% year-over-year, from $869K to $1.7M.
- What is the long-term trend for Ironwood Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's interest income has grown at a 53.9% compound annual growth rate (CAGR), from $726K to $4.08M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.